Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details)

v3.21.2
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Totals 9,317,282 5,345,321 9,317,282 5,345,321
Options to Purchase Common Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Totals 1,448,193 1,060,254 1,448,193 1,060,254
Restricted Stock Unvested [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Totals 520,167 520,167
Series H-1, H-3, H-4, H-5, I, J, pre-merger AYRO Merger Common Stock Purchase Warrants and Post-merger AYRO Warrants Issued [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Totals 7,346,447 4,006,205 7,346,447 4,006,205
Series H, H-3, H-6, and Pre-merger AYRO Seed Preferred Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Totals 2,475 278,862 2,475 278,862